-
Salvianolic Acid B, LH2, and Pulmonary Fibrosis
2026-08-15
The reference study identifies Salvianolic acid B, also known as Dan Shen Suan B, as a natural compound that reduces pulmonary fibrotic remodeling by lowering lysyl hydroxylase 2 expression and collagen cross-linking. Its combined cellular and tissue-level evidence positions LH2-associated matrix modification as a mechanistically important target for antifibrotic research, while leaving questions about direct molecular binding and clinical translation unresolved.
-
6-Thioguanine Chitosan Nanoparticles in Cancer Models
2026-08-14
The reference study developed 6-thioguanine-loaded chitosan nanoparticles and evaluated them as a sustained-release anticancer formulation, with or without curcumin. Nanoparticle delivery improved apparent activity in MCF-7 and PA-1 cells and was associated with apoptosis, G2/M arrest, and DNA-demethylating activity, although the findings remain limited to in vitro models.
-
STING Agonist-1 and B-Cell Immunity in ESCC
2026-08-14
A translational perspective on how STING agonist-1 can help dissect the CD40–STING–TRAF2–IRF4 axis, tertiary lymphoid structures, and B-cell activation in esophageal squamous cell carcinoma research.
-
HyperScript RT SuperMix for qPCR in Mitophagy
2026-08-13
HyperScript RT SuperMix for qPCR supports reproducible cDNA synthesis for qPCR when RNA is scarce or structurally challenging. Using PINK1/Park2-mediated mitophagy research as a case study, this article connects reverse-transcription design with stronger biological interpretation.
-
BAPTA-AM Workflows for Intracellular Calcium Control
2026-08-13
BAPTA-AM combines cell entry with selective intracellular calcium buffering, making it useful for mechanistic neurotoxicity studies, apoptosis assays, and calcium-imaging workflows. This practical guide translates evidence from organophosphorus-induced delayed neuropathy research into loading, control, readout, and troubleshooting strategies.
-
DSB-Induced ssBIR in Fully Grown Mouse Oocytes
2026-08-12
The reference study identifies short-scale break-induced replication (ssBIR) as a DNA synthesis response to double-strand breaks in fully grown mouse oocytes. EdU incorporation, damage-marker analysis, and pathway-inhibitor experiments indicate that Rad51-dependent strand invasion and replication activity can amplify DNA damage in this specialized G2-phase cell state.
-
ATF5 Peptide Reprograms CYP2B6 in Glioblastoma
2026-08-12
A 2025 study identifies ATF5 as a regulator of CYP2B6 in glioblastoma cells and shows that a TAT-fused dominant-negative ATF5 peptide can reduce CYP2B6 protein levels in selected models. The work connects transcription-factor biology with tumor drug metabolism, providing a mechanistic foundation for future pharmacogenomic dosing and drug-combination studies.
-
4-Phenylbutyric Acid in ER Stress Assays
2026-08-11
Explore how 4-Phenylbutyric acid and 4-PBA can strengthen mechanistic studies of ER stress, autophagy, and cancer-cell death. This article translates a recent liver cancer study into practical assay decisions, controls, and interpretation strategies.
-
Acetylcysteine Workflows for Redox Research
2026-08-11
Acetylcysteine supports controlled redox perturbation, glutathione-focused assays, mucosal studies, and disease-model workflows. This guide translates its antioxidant and disulfide-reducing chemistry into practical controls for oxidative stress experiments and reference-inspired cancer nanomedicine studies.
-
PFOS-Induced Ferroptosis and ER Stress in HK-2 Cells
2026-08-10
The reference study shows that perfluorooctane sulfonate (PFOS) injures human proximal tubular HK-2 cells through coordinated ferroptosis-associated biochemical changes and activation of the endoplasmic reticulum stress pathway. Its value lies in connecting renal tubular injury markers with altered iron, lipid peroxidation, antioxidant defense, and ER-stress signaling, providing a focused in vitro framework for environmental nephrotoxicity research.
-
Decitabine: Dose-Resolved Immune Epigenetics
2026-08-09
Decitabine (5-Aza-2'-deoxycytidine) is best understood through dose-resolved assays that separate epigenetic remodeling from cytotoxicity. This guide connects DNMT1 trapping, T-cell homeostasis, and translational assay design for cancer epigenetics and immune research.
-
Leonurine Targets Endothelial STING in DIC
2026-08-08
A 2026 Advanced Science study identifies cardiac vascular endothelial cells as early sensors and amplifiers of doxorubicin-induced cardiomyopathy. It shows that leonurine interrupts a cGAS–STING–NF-κB–NLRP3 injury circuit and limits extracellular-vesicle-mediated mitochondrial damage in cardiomyocytes, suggesting an endothelial-focused therapeutic strategy.
-
Capillarisenol C and ER Stress-Driven Autophagic Death
2026-08-07
The reference study identifies capillarisenol C, a bisphenol isolated from Artemisia capillaris, as an inducer of ER stress-mediated cytotoxic autophagy in liver cancer cells. Its combined pharmacological, molecular, and genetic evidence positions the PERK–eIF2α and IRE1 responses as important determinants of capillarisenol C-associated cell death rather than apoptosis alone.
-
Marein Reverses ABCG2-Mediated Mitoxantrone Resistance in Ca
2026-08-07
The referenced study demonstrates that marein, a flavonoid from Coreopsis tinctoria, restores chemosensitivity in multidrug-resistant cancer cells by competitively inhibiting the ABCG2 transporter. This mechanistic insight provides a targeted strategy for overcoming resistance to topoisomerase II inhibitors such as Mitoxantrone, with significant implications for optimizing combination therapies in oncology research.
-
Harnessing PDGF Receptor Inhibition: Strategic Guidance for
2026-08-06
This thought-leadership article delivers actionable insights for translational researchers targeting platelet-derived growth factor (PDGF) signaling. It contextualizes the mechanistic potency of JNJ-10198409 as a nanomolar ATP-competitive PDGF-BB receptor inhibitor, bridges competitive landscape analysis, and synthesizes the latest evidence from viral-host kinase signaling studies to illuminate new research frontiers. The article grounds each claim with evidence links and protocol recommendations, offering a practical, strategic roadmap for impactful antiangiogenic and antiproliferative research.